Cargando…
Biodistribution and efficacy of an anti-TENB2 antibody-drug conjugate in a patient-derived model of prostate cancer
TENB2, a transmembrane proteoglycan protein, is a promising target for antibody drug conjugate (ADC) therapy due to overexpression in human prostate tumors and rapid internalization. We previously characterized how predosing with parental anti-TENB2 monoclonal antibody (mAb) at 1 mg/kg in a patient-...
Autores principales: | Boswell, C. Andrew, Yadav, Daniela Bumbaca, Mundo, Eduardo E., Yu, Shang-Fan, Lacap, Jennifer Arca, Fourie-O’Donohue, Aimee, Kozak, Katherine R., Ferl, Gregory Z., Zhang, Crystal, Ho, Jason, Ulufatu, Sheila, Khawli, Leslie A., Lin, Kedan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817444/ https://www.ncbi.nlm.nih.gov/pubmed/31692898 http://dx.doi.org/10.18632/oncotarget.27263 |
Ejemplares similares
-
Effects of Anti-VEGF on Predicted Antibody Biodistribution: Roles of Vascular Volume, Interstitial Volume, and Blood Flow
por: Boswell, C. Andrew, et al.
Publicado: (2011) -
Quantitative cumulative biodistribution of antibodies in mice: Effect of modulating binding affinity to the neonatal Fc receptor
por: Yip, Victor, et al.
Publicado: (2014) -
ImmunoPET helps predicting the efficacy of antibody-drug conjugates targeting TENB2 and STEAP1
por: Williams, Simon-Peter, et al.
Publicado: (2016) -
Site-specific conjugation allows modulation of click reaction stoichiometry for pretargeted SPECT imaging
por: Mandikian, Danielle, et al.
Publicado: (2018) -
Prediction of non-linear pharmacokinetics in humans of an antibody-drug conjugate (ADC) when evaluation of higher doses in animals is limited by tolerability: Case study with an anti-CD33 ADC
por: Figueroa, Isabel, et al.
Publicado: (2018)